These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27455352)

  • 1. Corrigendum to: "The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis" [J. Affect. Disord. 190 (2016) 264-271].
    Zhao QF; Tan L; Wang HF; Jiang T; Tan MS; Tan L; Xu W; Li JQ; Wang J; Lai TJ; Yu JT
    J Affect Disord; 2016 Dec; 206():8. PubMed ID: 27455352
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "The effect of psychotherapeutic interventions on positive and negative affect in depression: A systematic review and meta-analysis" [J. Affect. Disord. 202 (2016) 153-162].
    Boumparis N; Karyotaki E; Kleiboer A; Hofmann SG; Cuijpers P
    J Affect Disord; 2017 Apr; 213():223. PubMed ID: 28161114
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of neuropsychiatric symptoms in Alzheimer's disease: a cross-sectional descriptive study in Thailand.
    Charernboon T; Phanasathit M
    J Med Assoc Thai; 2014 May; 97(5):560-5. PubMed ID: 25065098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Physical activity and sedentary behavior in people with major depressive disorder: A systematic review and meta-analysis" [J. Affect. Disord. 210 (2017) 139-150].
    Schuch F; Vancampfort D; Firth J; Rosenbaum S; Ward P; Reichert T; Carvalho Bagatini N; Bgeginski R; Stubbs B
    J Affect Disord; 2018 Jan; 225():79. PubMed ID: 28802116
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review." J Affect Disord. 241 (2018) 519-532.
    Lee Y; Ragguett RM; Mansur RB; Boutilier JJ; Rosenblat JD; Trevizol A; Brietzke E; Lin K; Pan Z; Subramaniapillai M; Chan TCY; Fus D; Park C; Musial N; Zuckerman H; Chen VC; Ho R; Rong C; McIntyre RS
    J Affect Disord; 2020 Sep; 274():1211-1215. PubMed ID: 32663953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Comparison of comorbid depression between irritable bowel syndrome and inflammatory bowel disease: A meta-analysis of comparative studies" [J Affect Disord. 2018 237: 37-46. doi: 10.1016/j.jad.2018.04.111.].
    Geng Q; Zhang QE; Wang F; Zheng W; Ng CH; Ungvari GS; Wang G; Xiang YT
    J Affect Disord; 2019 Jun; 253():. PubMed ID: 30658848
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "A systematic review of the prevalence of anxiety among the general population during the COVID-19 pandemic" [J. Affect. Disord. 293 (2021) 391-398 (Oct 1)].
    Kan FP; Raoofi S; Rafiei S; Khani S; Hosseinifard H; Tajik F; Raoofi N; Ahmadi S; Aghalou S; Torabi F; Dehnad A; Rezaei S; Hosseinipalangi Z; Ghashghaee A
    J Affect Disord; 2022 Sep; 312():337. PubMed ID: 35717358
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study.
    Peters ME; Schwartz S; Han D; Rabins PV; Steinberg M; Tschanz JT; Lyketsos CG
    Am J Psychiatry; 2015 May; 172(5):460-5. PubMed ID: 25585033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1].
    Mischoulon D; Hylek L; Yeung AS; Clain AJ; Baer L; Cusin C; Ionescu DF; Alpert JE; Soskin DP; Fava M
    J Affect Disord; 2018 Feb; 227():198. PubMed ID: 29100152
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Decreased plasma adiponectin among male firefighters with symptoms of post-traumatic stress disorder" [J. Affect. Disord. 221 (2017) 254-258].
    Na KS; Kim E; Park JT
    J Affect Disord; 2018 Jan; 225():657. PubMed ID: 28892794
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Prevalence and correlates of major depressive disorder and dysthymia in an eleven-year follow-up - Results from the Finnish Health 2011 Survey" [J. Affect. Disord. 173 (2015) 73-80].
    Markkula N; Suvisaari J; Saarni SI; Pirkola S; Peña S; Saarni S; Ahola K; Mattila AK; Viertiö S; Strehle J; Koskinen S; Härkänen T
    J Affect Disord; 2017 Feb; 209():16-17. PubMed ID: 27866045
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Communication attitudes in children who stutter: A meta-analytic review" [J. Fluency Disord. 46C (2015) 1-14].
    Guttormsen LS; Kefalianos E; Naess KB
    J Fluency Disord; 2018 Jun; 56():122. PubMed ID: 29735345
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's disease" [Parkinsonism Relat. Disord. 25C (2016) 58-64].
    Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J
    Parkinsonism Relat Disord; 2016 Oct; 31():161. PubMed ID: 27567724
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study.
    van Vliet D; de Vugt ME; Aalten P; Bakker C; Pijnenburg YA; Vernooij-Dassen MJ; Koopmans RT; Verhey FR
    Dement Geriatr Cogn Disord; 2012; 34(5-6):319-27. PubMed ID: 23208452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Diagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Hu YB; Li CB; Song N; Zou Y; Chen SD; Ren RJ; Wang G
    Front Aging Neurosci; 2017; 9():35. PubMed ID: 28261090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric symptoms in patients with Alzheimer's disease with a vascular component.
    Bidzan M; Bidzan L; Pachalska M
    Ann Agric Environ Med; 2014; 21(2):412-5. PubMed ID: 24959800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to "Global cognitive effects of second-generation antidepressants in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials" [J. Psychiatr. Res. 155 (2022) 371-379].
    Qin M; Wu J; Zhou Q; Liang Z; Su Y
    J Psychiatr Res; 2022 Dec; 156():44. PubMed ID: 36242942
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Network analysis of anxiety and depressive symptoms among nursing students during the COVID-19 pandemic" [J. Affect. Disord. 294 (2021): 753-760].
    Bai W; Xi HT; Zhu Q; Ji M; Zhang H; Yang BX; Cai H; Liu R; Zhao YJ; Chen L; Ge ZM; Wang Z; Han L; Chen P; Liu S; Cheung T; Tang YL; Jackson T; An F; Xiang YT
    J Affect Disord; 2023 May; 328():355. PubMed ID: 36774316
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to: "Prevalence of major depressive disorder and socio-demographic correlates: Results of a representative household epidemiological survey in Beijing, China" [J. Affect. Disord. 179 (2015) 74-81].
    Liu J; Yan F; Ma X; Guo HL; Tang YL; Rakofsky JJ; Wu XM; Li XQ; Zhu H; Guo XB; Yang Y; Li P; Cao XD; Li HY; Li ZB; Wang P; Xu QY
    J Affect Disord; 2016 Jun; 197():8. PubMed ID: 27090235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.